Status:
COMPLETED
Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis
Lead Sponsor:
Sanjiv Sam Gambhir
Conditions:
Brain Cancer
Arthritis, Rheumatoid
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine whether \[18F\]FHBG is suitable for use as an imaging probe in cancer or rheumatoid arthritis patients enrolled in cell or gene therapy trials. In this phase ...
Detailed Description
The success of cell and gene therapy depends on specific targeting of the therapeutic gene or cell that is administered to the patient. Our goal is to develop an imaging method to non-invasively monit...
Eligibility Criteria
Inclusion
- \- Clinical diagnosis of brain tumor or rheumatoid arthritis
Exclusion
- \- Below 18 years of age
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00185848
Start Date
April 1 2005
End Date
June 1 2013
Last Update
March 14 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California Los Angeles
Los Angeles, California, United States, 90095
2
Stanford University School of Medicine
Stanford, California, United States, 94305